Micronesia (country) vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB
Micronesia (country)
100.0%
in 2017
South-East Asia (WHO region)
77.0%
in 2022
Micronesia (country) rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate for patients treated for MDR-TB over time
- Micronesia (country)
- South-East Asia (WHO region)
How they compare
Micronesia (country) currently reports 100.0% against 77.0% in South-East Asia (WHO region), a difference of 23.0%.
That makes Micronesia (country)'s figure about 1.3 times South-East Asia (WHO region)'s.
The two have swapped places 1 time across 7 shared years of data; in 2007 it was South-East Asia (WHO region) ahead.
Micronesia (country) ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
Across the 2 decades both report, Micronesia (country) averaged higher in 1 and South-East Asia (WHO region) in 1.
Head to head by decade
| Decade | Micronesia (country) | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.7% | 61.7% | 31.0% | South-East Asia (WHO region) |
| 2010s | 100.0% | 51.5% | 48.5% | Micronesia (country) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Micronesia (country) or South-East Asia (WHO region)?
- Micronesia (country), at 100.0% against 77.0% in South-East Asia (WHO region) as of 2017.
- What is the difference in treatment success rate for patients treated for mdr-tb between Micronesia (country) and South-East Asia (WHO region)?
- 23.0%, with Micronesia (country) ahead.
- How many years of comparable data are there for Micronesia (country) and South-East Asia (WHO region)?
- 7 years are reported by both, from 2007 to 2017.
- How do Micronesia (country) and South-East Asia (WHO region) rank globally for treatment success rate for patients treated for mdr-tb?
- Micronesia (country) ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.